Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cristina Villanueva-Bueno, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Álvaro Giménez-Manzorro, Almudena Ribed, Belén Marzal-Alfaro, José Luis Revuelta-Herrero, Eva Gonzalez-Haba, Ana Herranz & Maria Sanjurjo. (2022) Medication guide for the perioperative management of oral antineoplastic agents in cancer patients. Expert Opinion on Drug Safety 21:1, pages 107-119.
Read now
Read now
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Angela Hoyo-Muñoz, Alvaro Gimenez-Manzorro, Antonio Calles, Santiago Osorio, Ana Herranz-Alonso & Maria Sanjurjo-Sáez. (2020) Potential drug interactions between targeted oral antineoplastic agents and concomitant medication in clinical practice. Expert Opinion on Drug Safety 19:8, pages 1041-1048.
Read now
Read now
Julieta González, Matías Quiroga, Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Ana Herranz-Alonso & María Sanjurjo Sáez. (2018) Posology adjustments of oral antineoplastic agents for special populations: patients with renal impairment, hepatic impairment and hematologic toxicities. Expert Opinion on Drug Safety 17:6, pages 553-572.
Read now
Read now
Ivo Abraham, Luis Canais, Marti Larriva, Ali McBride, Reem Diri & Karen MacDonald. (2016) What does it take to provide cancer patients with comprehensive medication therapy management services for oral chemotherapy?. Expert Opinion on Drug Safety 15:4, pages 413-415.
Read now
Read now
Articles from other publishers (13)
Yanting Wang, Di Du, Jun Yang, Alan H. Lau, Yuanyuan Dai, Wangjun Qin, Ning Li & Guohui Li. (2022) Pharmacist-led olaparib follow-up service for ambulatory ovarian cancer patients: A prospective study in a tertiary specialized cancer hospital in China. Frontiers in Pharmacology 13.
Crossref
Crossref
Cristina Villanueva-Bueno, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, José Luis Revuelta-Herrero, María Belén Marzal-Alfaro, Eva González-Haba, José Ángel Arranz-Arija, Santiago Osorio, Ana Herranz-Alonso & María Sanjurjo-Saez. (2022) A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital. Frontiers in Public Health 10.
Crossref
Crossref
Vicente Escudero-Vilaplana, Lorena Romero-Medrano, Cristina Villanueva-Bueno, Marta Rodríguez de Diago, Alberto Yánez-Montesdeoca, Roberto Collado-Borrell, Juan José Campaña-Montes, Belén Marzal-Alfaro, José Luis Revuelta-Herrero, Antonio Calles, Mar Galera, Rosa Álvarez, Ana Herranz, María Sanjurjo & Antonio Artés-Rodríguez. (2022) Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App. Frontiers in Oncology 12.
Crossref
Crossref
Ningsheng Wang, Biqi Ren, Haisheng You, Yue Chen, Shuzhi Lin, Shuang Lei & Bianling Feng. (2022) Assessment of medication adherence, medication safety awareness and medication practice among patients with lung cancer: A multicentre cross‐sectional study. Health Expectations 25:2, pages 791-801.
Crossref
Crossref
Noelia Vicente-Oliveros, Teresa Gramage-Caro, Elena Corral de la Fuente, Eva Delgado-Silveira & Ana María Álvarez-Díaz. (2022) Analysis of adverse drug events as a way to improve cancer patient care. European Journal of Hospital Pharmacy, pages ejhpharm-2021-003199.
Crossref
Crossref
Gabriele Alvernaz Silva Franco, Liliane Faria da Silva, Flavio Luiz Seixas, Fernanda Garcia Bezerra Góes, Ana Carolina Alves Vollu & Eduardo Charpinel Lagoeiro. (2022) Necessidades de aprendizagem de familiares de crianças e adolescentes em tratamento com quimioterápicos antineoplásicos orais. Escola Anna Nery 26.
Crossref
Crossref
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Cristina Villanueva-Bueno, Rosa Álvarez, Ana Herranz & María Sanjurjo. (2020) Acute pancreatitis in a patient treated with imatinib and gefitinib. Journal of Oncology Pharmacy Practice 27:4, pages 980-983.
Crossref
Crossref
Célia Lachuer, Germain Perrin, Aymeric Chastel, Hail Aboudagga, Constance Thibault, Nicolas Delanoy, Eric Caudron & Brigitte Sabatier. (2020) Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross‐sectional study. European Journal of Cancer Care 30:3.
Crossref
Crossref
Cynara S Oliveira, Mauriele P Silva, Íngara K S P B Miranda, Rodrigo T Calumby & Renata F de Araújo-Calumby. (2020) Impact of clinical pharmacy in oncology and hematology centers: A systematic review. Journal of Oncology Pharmacy Practice 27:3, pages 679-692.
Crossref
Crossref
Emily Mackler, Eve M. Segal, Benyam Muluneh, Kate Jeffers & Jenna Carmichael. (2019) 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard. Journal of Oncology Practice 15:4, pages e346-e355.
Crossref
Crossref
R. Vera, M. J. Otero, F. Ayala de la Peña, C. González-Pérez, Á. Peñuelas, J. M. Sepúlveda, N. Quer, N. Doménech-Climent, J. A. Virizuela, P. Beorlegui & M. Q. Gorgas. (2018) Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients. Clinical and Translational Oncology 21:4, pages 467-478.
Crossref
Crossref
Jaqueline G. Hugtenburg, Lonneke Timmers & Jan Jacob Beckeringh. 2019. The Pharmacist Guide to Implementing Pharmaceutical Care. The Pharmacist Guide to Implementing Pharmaceutical Care
397
419
.
Laura A. Fennimore & Pamela K. Ginex. (2017) Oral Agents for Cancer Treatment. Nursing Clinics of North America 52:1, pages 115-131.
Crossref
Crossref